A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS

The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis

(2016) Ibrahim Koral ONAL et al.   Turkish Journal of Gastroenterology

Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis

(2014) Xing-lu Zhou et al.   BMC GASTROENTEROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

S100A Expression and Interleukin-10 Polymorphisms Are Associated with Ulcerative Colitis and Diarrhea Predominant Irritable Bowel Syndrome

(2013) Akiko Shiotani et al.   DIGESTIVE DISEASES AND SCIENCES

Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes

(2013) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Endothelial function and cardiovascular risk in active inflammatory bowel diseases

(2013) Mariabeatrice Principi et al.   Journal of Crohns & Colitis

Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity

(2013) Hans Strid et al.   Journal of Crohns & Colitis

Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

(2012) Stephen J Halpin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome

(2012) Chad K Porter et al.   BMC GASTROENTEROLOGY

Lipid peroxidation markers in Crohn’s disease: the associations and diagnostic value

(2012) Dorota Boehm et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Fecal Assays Detect Hypersensitivity to Cow's Milk Protein and Gluten in Adults With Irritable Bowel Syndrome

(2011) Antonio Carroccio et al.   Clinical Gastroenterology and Hepatology

Epidemiology of IBS

(2011) Rok Seon Choung et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

(2011) Michael J. Sydora et al.   Journal of Crohns & Colitis

Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity

(2011) K. A. Oikonomou et al.   JOURNAL OF GASTROENTEROLOGY

Faecal lactoferrin - a novel test to differentiate between the irritable and inflamed bowel?

(2010) R. SIDHU et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Yield of Colonoscopy in Patients With Non-Constipated Irritable Bowel Syndrome: Results From a Prospective, Controlled US Trial

(2010) William D Chey et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Is Irritable Bowel Syndrome a Diagnosis of Exclusion?: A Survey of Primary Care Providers, Gastroenterologists and IBS Experts

(2010) Brennan M R Spiegel et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome

(2009)   AMERICAN JOURNAL OF GASTROENTEROLOGY

Elevated Human β-Defensin-2 Levels Indicate an Activation of the Innate Immune System in Patients With Irritable Bowel Syndrome

(2009) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume

(2009) Osman Yüksel et al.   PLATELETS

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

(2008) M Henriksen et al.   GUT

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

(2007) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES